Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: A meta-analysis of 4 randomized double-blind studies

Archives of Internal Medicine

Volumn 162, Issue 16, 2002, Pages 1833-1840

  Turpie, Alexander G G ^a   Bauer, Kenneth A ^a   Eriksson, Bengt I ^a   Lassen, Michael R ^a  

^a HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A INHIBITOR; ENOXAPARIN; FONDAPARINUX; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DEEP VEIN THROMBOSIS; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HIP FRACTURE; HUMAN; KNEE SURGERY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MULTICENTER STUDY; ORTHOPEDIC SURGERY; PHLEBOGRAPHY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REOPERATION; THROMBOEMBOLISM; TOTAL HIP PROSTHESIS; TREATMENT OUTCOME;

AGED; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; CONFIDENCE INTERVALS; DOUBLE-BLIND METHOD; ENOXAPARIN; FEMALE; FIBRINOLYTIC AGENTS; FRACTURE FIXATION, INTERNAL; HIP FRACTURES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTICENTER STUDIES; ORTHOPEDIC PROCEDURES; POLYSACCHARIDES; RANDOMIZED CONTROLLED TRIALS; THROMBOEMBOLISM; TIME FACTORS; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 0037048227     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.16.1833     Document Type: Article

References (34)

1. Prevention of venous thromboembolism
2. Prevention of venous thromboembolism: International Consensus Statement: Guidelines compiled in accordance with the scientific evidence
3. Chemical synthesis of glycosaminoglycans: New approaches to antithrombotic drugs
4. The unique antithrombin III binding domain of heparin: A lead to new synthetic antithrombotics
5. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions: Resolution of the antithrombin conformational change contribution to heparin rate enhancement
6. The effect of the synthetic pentasaccharide SR90107/Org31540 on thrombin generation ex vivo is uniquely due to ATIII-mediated neutralization of factor Xa
7. The inhibition of the generation of thrombin and the antithrombotic effect of a pentasaccharide with sole anti-factor Xa activity
8. Pharmacokinetics of Org31540/SR90107A in young and elderly healthy subjects: A highly phamacokinetic profile
9. What are the most reliable detection methods for deep vein thrombosis and pulmonary embolism to be used as endpoints in trials of venous thromboprophylaxis
10. Noninvasive diagnosis of deep venous thrombosis
11. A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement
12. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: A randomised double-blind comparison
13. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: A randomised double-blind trial
14. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery
15. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery
16. Roentgen diagnosis of venous thrombosis in the leg
17. Value of the ventilation/perfusion scan in acute pulmonary embolism: Results of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED)
18. Prevention of deep-vein thrombosis after total hip replacement: Direct thrombin inhibition with recombinant hirudin, CGP 39393
19. A comparison of recombinant hirudin with low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement
20. Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty: A double-blind, randomized comparison
21. Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement surgery: A double-blind, dose-ranging study
22. Prevention of venous thromboembolism after knee arthroplasty: A randomized, double blind trial comparing enoxaparin with warfarin
23. Low molecular weight heparin in prevention of postoperative thrombosis
24. Clinical trials with low molecular weight heparins in the prevention of postoperative thromboembolic complications: A meta-analysis
25. Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery
26. Prophylaxis of postoperative thromboembolism with low molecular weight heparin
27. Efficacy and safety of low molecular weight heparin, unfractionated heparin and warfarin for thrombo-embolism prophylaxis in orthopaedic surgery: A meta-analysis of randomised clinical trials
28. Low molecular weight heparin in thrombosis prophylaxis after major surgical intervention: Update of previous meta-analyses
29. Low molecular weight heparin decreases proximal and distal venous thrombosis following total knee arthroplasty: A meta-analysis of randomized trials
30. Deep vein thrombosis and pulmonary embolism: An autopsy study with multiple regression analysis of possible risk factors
31. Is embolic risk conditioned by location of deep venous thrombosis?
32. Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement: Comparison of low-molecular-weight heparin and unfractionated heparin
33. A meta-analysis of methods to prevent venous thromboembolism following total hip replacement
34. A metaanalysis of thromboembolic prophylaxis following elective total hip arthroplasty